All In MedTech

FDA Clearance Tracker · N970012-S177

AMS 700 Implantable Penile Prosthesis (IPP) with and without Inhibizone Treatment

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 20, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
N970012-S177
Device name
AMS 700 Implantable Penile Prosthesis (IPP) with and without Inhibizone Treatment
Applicant location
Marlboro, MA
Received
Apr 20, 2020
Decided
May 20, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
N970012

Device type

Device class
Class III
Regulation
21 CFR 876.3350

Every decision under product code JCW

FDA's approval statement

As written in FDA's record.

Approval for a site change from the BSC Minnetonka, MN facility to the BSC St. Paul, Minnesota facility.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.